STOCKHOLM, July 1, 2021 /PRNewswire/ -- Medivir AB
(Nasdaq Stockholm: MVIR) announced today it has appointed
Malene Jensen as Vice President
Clinical Development. She will assume her role as VP Clinical
Development after the summer, at the latest October 1, 2021. Malene
Jensen will also join the company's executive team.
Malene Jensen has held various
leadership positions within Clinical Development in the
pharmaceutical industry for the past 15 years, including at
AstraZeneca, Affibody and most recently as Director Global Clinical
Development at Sedana Medical. She holds a PhD in Clinical
Neuroscience from Karolinska Institutet
in Stockholm.
"We are pleased to welcome Malene and her vast clinical
development experience to Medivir. Malene will focus on the
clinical trials with our key program, MIV-818, and she will be a
valuable member of the management team," said Magnus Christensen, Interim CEO of Medivir.
For additional information, please
contact
Magnus
Christensen
Interim CEO and CFO
Telephone: +46 8 5468 3100
E-mail: magnus.christensen@medivir.com
Medivir in brief
Medivir develops innovative drugs with a focus on cancer where
the unmet medical needs are high. The drug candidates are directed
toward indication areas where available therapies are limited or
missing and there are great opportunities to offer significant
improvements to patients. Medivir is focusing on the development of
MIV-818, a pro-drug designed to selectively treat liver cancer
cells and to minimize side effects.Collaborations and partnerships
are important parts of Medivir's business model, and the drug
development is conducted either by Medivir or in partnership.
Birinapant, a SMAC mimetic, is exclusively outlicensed to IGM
Biosciences (Nasdaq: IGMS) to be developed in combination with
IGM-antibodies for the treatment of solid tumors. Medivir's share
(ticker: MVIR) is listed on Nasdaq Stockholm's Small Cap list.
www.medivir.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/medivir/r/medivir-appoints-malene-jensen-as-vp-clinical-development,c3378301
The following files are available for download:
|
https://mb.cision.com/Main/652/3378301/1439725.pdf
|
Press release
(PDF)
|
View original
content:https://www.prnewswire.com/news-releases/medivir-appoints-malene-jensen-as-vp-clinical-development-301324486.html
SOURCE Medivir
